Angiotensin II infusion in COVID‐19: An international, multicenter, registry‐based study.

MLA

Serpa Neto, Ary, et al. “Angiotensin II Infusion in COVID‐19: An International, Multicenter, Registry‐based Study.” Journal of Medical Virology, vol. 94, no. 5, May 2022, pp. 2079–88. EBSCOhost, https://doi.org/10.1002/jmv.27592.

APA

Serpa Neto, A., Landoni, G., Ostermann, M., Lumlertgul, N., Forni, L., Alvarez, B. L., Trapani, T., Alliegro, P. V., Zacharowski, K., Wiedenbeck, C., de Backer, D., & Bellomo, R. (2022). Angiotensin II infusion in COVID‐19: An international, multicenter, registry‐based study. Journal of Medical Virology, 94(5), 2079–2088. https://doi.org/10.1002/jmv.27592

Chicago

Serpa Neto, Ary, Giovanni Landoni, Marlies Ostermann, Nuttha Lumlertgul, Lui Forni, Belon, Lucas Alvarez, Tony Trapani, et al. 2022. “Angiotensin II Infusion in COVID‐19: An International, Multicenter, Registry‐based Study.” Journal of Medical Virology 94 (5): 2079–88. doi:10.1002/jmv.27592.